Total Payments
$4,673
2024 Payments
$852.48
Companies
24
Transactions
66
Medicare Patients
213
Medicare Billing
$2,311
Payment Breakdown by Category
Food & Beverage$4,673 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,673 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $541.05 | 9 | $0 (2024) |
| Lilly USA, LLC | $526.35 | 7 | $0 (2019) |
| Novo Nordisk Inc | $523.48 | 7 | $0 (2024) |
| Amgen Inc. | $464.35 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $368.32 | 4 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $362.41 | 3 | $0 (2024) |
| AbbVie, Inc. | $299.32 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $249.03 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $248.16 | 2 | $0 (2019) |
| SANOFI PASTEUR INC. | $169.95 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $852.48 | 12 | Novo Nordisk Inc ($281.93) |
| 2023 | $421.34 | 6 | Amgen Inc. ($342.23) |
| 2022 | $509.05 | 7 | GlaxoSmithKline, LLC. ($239.21) |
| 2021 | $176.05 | 8 | Nestle HealthCare Nutrition Inc. ($117.88) |
| 2020 | $61.15 | 3 | Nestle HealthCare Nutrition Inc. ($48.15) |
| 2019 | $563.39 | 10 | Lilly USA, LLC ($175.50) |
| 2018 | $721.85 | 6 | AstraZeneca Pharmaceuticals LP ($249.03) |
| 2017 | $1,367 | 14 | SANOFI-AVENTIS U.S. LLC ($243.62) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Vaccines | ||||||
| 09/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $139.56 | General |
| Category: Neuroscience | ||||||
| 09/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ANTIBIOTIC | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.18 | General |
| 05/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 05/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardio-renal | ||||||
| 04/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: Diabetes | ||||||
| 03/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardio-renal | ||||||
| 01/26/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $122.12 | General |
| Category: Bone Health | ||||||
| 11/03/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $120.16 | General |
| Category: Bone Health | ||||||
| 05/24/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, BEXSERO | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2023 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| Category: Allergy/Immunology | ||||||
| 03/06/2023 | SANOFI PASTEUR INC. | VAXELIS (Biological), MENQUADFI | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Vaccines | ||||||
| 02/15/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $101.92 | General |
| Category: Inflammation | ||||||
| 02/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $120.15 | General |
| Category: Cardiology | ||||||
| 11/16/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: VACCINES | ||||||
| 10/31/2022 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $20.07 | General |
| Category: Cranial Orthotic | ||||||
| 09/29/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: VACCINES | ||||||
| 09/27/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: VACCINES | ||||||
| 06/30/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $97.49 | General |
| Category: VACCINES | ||||||
| 06/22/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 04/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 71 | 148 | $1,630 | $796.89 |
| 2022 | 2 | 58 | 136 | $1,468 | $712.60 |
| 2021 | 2 | 36 | 76 | $722.00 | $410.03 |
| 2020 | 2 | 48 | 72 | $655.00 | $391.32 |
Total Patients
213
Total Services
432
Medicare Billing
$2,311
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 51 | $957.00 | $485.52 | 50.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 39 | 97 | $673.00 | $311.37 | 46.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 26 | 43 | $817.00 | $411.97 | 50.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 32 | 93 | $651.00 | $300.63 | 46.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 15 | 25 | $437.00 | $242.75 | 55.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 21 | 51 | $285.00 | $167.28 | 58.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 20 | 25 | $425.00 | $240.47 | 56.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 28 | 47 | $230.00 | $150.85 | 65.6% |
About Dr. Arthur Manoukian, M.D
Dr. Arthur Manoukian, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811948540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Manoukian, M.D has received a total of $4,673 in payments from pharmaceutical and medical device companies, with $852.48 received in 2024. These payments were reported across 66 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,673).
As a Medicare-enrolled provider, Manoukian has provided services to 213 Medicare beneficiaries, totaling 432 services with total Medicare billing of $2,311. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Adolescent Medicine
- Location Pasadena, CA
- Active Since 05/15/2006
- Last Updated 01/29/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811948540
Products in Payments
- TRULICITY (Drug) $459.77
- EVENITY (Biological) $242.28
- SOLIQUA (Drug) $239.79
- SHINGRIX (Biological) $239.21
- Creon (Drug) $231.90
- XARELTO (Drug) $222.85
- JARDIANCE (Drug) $190.30
- ZENPEP (Drug) $166.03
- AREXVY (Drug) $154.97
- BEXSERO (Biological) $146.87
- SPRAVATO (Drug) $139.56
- VRAYLAR (Drug) $131.53
- TOUJEO (Drug) $128.53
- AJOVY (Drug) $125.07
- ULTOMIRIS (Biological) $125.00
- BEYFORTUS (Biological) $124.99
- Tresiba (Drug) $124.99
- BEVESPI AEROSPHERE (Drug) $124.78
- FARXIGA (Drug) $124.25
- Repatha (Biological) $120.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882